widely used chemical linkage for ODN conjugation. This is
due to the fact that reactions leading to the formation of
oxime bonds are chemoselective and give high coupling
efficiency. Furthermore, these bonds are stable over a wide
pH range. Oxime bond formation has been extensively used
for the preparation of ODN conjugates with peptides,14
carbohydrates,15 and fluorescent probes.16 It has been shown
that ODN-glyoxylic aldehyde (R-ketoaldehyde)17 is more
stable to air oxidation and does not react with amino groups
during ligation. These glyoxylic aldehyde functionalities are
usually generated by periodate oxidation of a serine moiety
and have been extensively used in protein engineering.18
However, only a few methods have been reported in literature
that can be used to prepare ODN 5′-conjugates through
glyoxylic oxime bond formation.17,19 To the best of our
knowledge, there is no known method available for the
preparation of ODN 3′-conjugates by a similar method.
Recently, a method to prepare peptide-oligonucleotide
conjugates (POCs) through glyoxylic oxime linkage was
reported from our laboratory.19 The glyoxylic aldehyde linker
was incorporated at the 5′ extremity of ODN by using a novel
serine-containing phosphoramidite. The glyoxylic aldehyde
function was generated by the oxidation of the serine moiety,
and it was also shown that a glyoxylic oxime linkage is more
stable than an aldoxime linkage at acidic to neutral pH. It
was therefore decided to develop a protocol for the prepara-
tion of ODN 3′-conjugates through glyoxylic oxime bond
formation. This is of significant interest because 3′-modified
ODNs show greater resistance to nuclease activity compared
to 5′-analogues. Furthermore, 3′-conjugation keeps the 5′-
terminus free for 32P-labeling by kinase, which is a very
widespread technique used in molecular biology for DNA
gel analysis.
Figure 1. Solid support 1.
eptide motif is known to be a selective and powerful ligand
for Rvâ3 integrin receptors.20 The NLS peptide is a nuclear
localizing signal sequence with basic peptide APKKKRKVED
derived from the simian virus 40 antigen. The hydrolytic
stability of the 3′-glyoxylic oxime linkage was investigated
and compared to the stability of the 3′-aldoxime linkage.
The new long-chain alkyl amine-controlled pore glass
(LCAA-CPG) solid support 1 was prepared from com-
mercially available N-R-Fmoc-O-tBu-L-serine 2 in few
chemical steps (Scheme 1). 2 was converted to pentafluo-
Scheme 1. Preparation of Solid Support 1
We report, herein, a new and convenient procedure to
prepare oligonucleotides modified with glyoxylic aldehyde
at the 3′-terminus. This has been achieved by synthesizing
a novel solid support 1 for ODN synthesis and modification
(Figure 1). 6-mer and 11-mer oligonucleotide sequences
modified with 3′-glyoxylic aldehyde group were prepared
using this support. The efficiency of this procedure for 3′-
conjugation was investigated by coupling these ODN se-
quences to aminooxy-containing peptides (sequences con-
taining a RGD and NLS motif, respectively) and a fluorescein
derivative. The arginine-glycine-aspartic acid (RGD) trip-
t
rophenyl ester using pentafluorophenol/DCC. The Bu pro-
tecting group was removed using 100% trifluoroacetic acid
to obtain 3. This on N-acylation with 1-O-dimethoxytrityl-
6-amino-1-hexanol 4 gave compound 5. The procedure to
prepare protected amino linker 4 has been described earlier.21
It should be mentioned that â-hydroxy protected N-R-Fmoc-
O-tBu-L-serine 2 was used as the starting material instead
of â-hydroxy unprotected N-R-Fmoc-L-serine because the
latter compound showed significant side reactions on either
conversion to pentafluorenyl ester or acylation with 4 under
standard peptide coupling conditions. The synthon 5 was
anchored onto the solid support by using the “classical”
succinyl linker. The succinyl linker was attached at the
â-hydroxyl function of 5 via an esterification reaction with
succinic anhydride to obtain 6. The acid 6 was finally
attached to the solid support by reaction with the amino
(14) (a) Edupuganti, O. P.; Singh, Y.; Defrancq, E.; Dumy, P. Chem.-
Eur. J. 2004, 10, 5988-5995. (b) Zatsepin, T. S.; Stetsenko, D. A.;
Arzumanov, A. A.; Romanova, E. A.; Gait, M. J.; Oretskaya, T. S.
Bioconjugate Chem. 2002, 13, 822-830.
(15) (a) Singh, Y.; Renaudet, O.; Defrancq, E.; Dumy, P. Org. Lett. 2005,
7, 1359-1362. (b) Dey, S.; Sheppard, T. L. Org. Lett. 2001, 3, 3983-
3986.
(16) (a) Tre´visiol, E.; Renard, A.; Defrancq, E.; Lhomme, J. Nucleosides
Nucleotides Nucleic Acids 2000, 19, 1427-1439. (b) Salo, H.; Virta, P.;
Hakala, H.; Prakash, T. P.; Kawasaki, A. M.; Manoharan, M.; Lo¨nnberg,
H. Bioconjugate Chem. 1999, 10, 815-823.
(17) Far, S.; Gouyette, C.; Melnyk, O. Tetrahedron 2005, 61, 6138-
6142.
(18) (a) Liu, H.; Wang, L.; Brock, A.; Wong, C.-H.; Schultz, P. G. J.
Am. Chem. Soc. 2003, 125, 1702-1703. (b) Olivier, C.; Hot, D.; Huot, L.;
Ollivier, N.; El-Mahdi, O.; Gouyette, C.; Huynh-Dinh, T.; Gras-Masse, H.;
Lemoine, Y.; Melnyk, O. Bioconjugate Chem. 2003, 14, 430-439.
(19) Singh, Y.; Defrancq, E.; Dumy, P. J. Org. Chem. 2004, 69, 8544-
8546.
(20) Aumailley, M.; Gurrath, M.; Muller, G.; Calvete, J.; Timpl, R.;
Kessler, H. FEBS Lett. 1991, 291, 50-54.
(21) Avino, A.; Guimil Garcia, R.; Albericio, F.; Mann, M.; Wilm, M.;
Neubauer, G.; Eritja, R. Bioorg. Med. Chem. 1996, 4, 1649-1658.
220
Org. Lett., Vol. 9, No. 2, 2007